{"name":"Intuitive Surgical","slug":"intuitive","ticker":"ISRG","exchange":"NASDAQ","domain":"intuitive.com","description":"Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.","hq":"Sunnyvale, CA","founded":0,"employees":"17021","ceo":"Gary S. Guthart","sector":"Surgical Robotics","stockPrice":468.96,"stockChange":16.01,"stockChangePercent":3.53,"marketCap":"$166.6B","metrics":{"revenue":10064700000,"revenueGrowth":18.8,"grossMargin":66,"rdSpend":1311800000,"netIncome":2856000000,"cash":5934900224,"dividendYield":0,"peRatio":59.5,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Intuitive Surgical Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Intuitive Surgical reported fourth quarter and full year 2023 financial results, with revenue of $1.44 billion and $5.73 billion, respectively.","drugName":"","sentiment":"positive"},{"date":"2023-11-01","type":"deal","headline":"Intuitive Surgical Partners with Cleveland Clinic to Enhance Surgical Training","summary":"Intuitive Surgical partnered with Cleveland Clinic to enhance surgical training and education for surgeons using the da Vinci Surgical System.","drugName":"","sentiment":"neutral"},{"date":"2023-08-01","type":"regulatory","headline":"FDA Clears Intuitive Surgical's da Vinci SP Surgical System for Use in Urology","summary":"The FDA cleared Intuitive Surgical's da Vinci SP Surgical System for use in urology, expanding the system's indications.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQcXlpc1h3XzFfTTkxWU13aUljc3VFVGFZRXk3WXg5YkxLMHJKM3NBTkxOM3hTeTBESU82N1lBY3pPYU1TR0xxcHM3eXNiYVgxNjlxaE5UaFFrSndSeU41Q2tkSmpheVFGMXh1cU9DSHptZE1hV2M0VFFqbmlHU1RMNUEtU1IzY0JpT1BvQnhkMjRzMWhlUU1BM05qbnhvQ2ZTbGZtb1dYcVV1d1E5MkRfYk83dzJldWpJMm5yWg?oc=5","date":"2026-02-12","type":"earnings","source":"TradingView","summary":"WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - TradingView","headline":"WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQMjBTMDNIVHhtUkFobF9uNngtN0ExeG1JenBxUzdVZS05R1FnU0FrNGx6TFpPS2tsYThVb1h5LVBBeW1JUGxER1NGVUR1UUd6VTAyYmdKb3dYenBZMTd5MG9sbGJFc042cGNvTzlSQ0Z4VmkwdkxWZFZJNW1ZUlBpU25saTY3d0xDYkpCd3NB?oc=5","date":"2026-02-07","type":"deal","source":"The Motley Fool","summary":"2 Top Healthcare Stocks to Buy in February - The Motley Fool","headline":"2 Top Healthcare Stocks to Buy in February","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1KT2g1LXpPRVhQM21tUU9TWU5lcU0zV1hBRHNqS1lRVWVCc1JKWXh4a2VFN1dCbVdDYmpOSUdwdGlLelNZTlR2aURpTlhJUUJNVFJmYm1GZ1hGSzc1WGduRHg4TFZCRDZIOHZXX29wblowR2ZrNm1oSUhReXFxZw?oc=5","date":"2026-02-07","type":"deal","source":"Yahoo Finance","summary":"2 Top Healthcare Stocks to Buy in February - Yahoo Finance","headline":"2 Top Healthcare Stocks to Buy in February","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE4wWWxFWEowUlVLWEZmVVMzdkM4WUM5MGtjRW5UcW9kR2JJa1Q3TExEeUVzVGFYUDFyV01VSWk5eUd3eHAzY1NUc3paZWR3cl9EVlNRdDRSM2tIOFo1QzNvSDdna3BwMHlOSDZtVGpjcmR5QlV3VWNZYkJseVg2aUE?oc=5","date":"2026-01-06","type":"pipeline","source":"Yahoo Finance","summary":"The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson - Yahoo Finance","headline":"The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOU1ZTSW1TdXNaOXJITWJ0MTlHOXdDRkVwR19zaTl2MV82SWNWeGxzb29LeEhPZ2hqYlhNVW5fYnpGVnY4c1VRZ1Q1VnVvNVcyQ3h1YnBmTUxLdkZ2V25FX092QVhNVHlpYU91ZF9Ta2QtcjMwR0pLU2d1VTJFZkhjTXZtY29xZw?oc=5","date":"2026-01-03","type":"pipeline","source":"Nanalyze","summary":"5 Biotech Stocks We Like in 2026. And 5 We Don’t - Nanalyze","headline":"5 Biotech Stocks We Like in 2026. And 5 We Don’t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxObFM2aG1ZdnJJb0dMUnptZlN1OC1WdkNSamlaM3FidF9rSHlwYlRLb2RFYWJISWFkVlMxLS1rc1Y0LVptSDc3d1hhRzZlVWlZeGxuX1hTcHJITWNRbXZGUzFjWjJFejlEcnhnSWxyR3RqMi04MHJBWmVrM3Q0QXNkLV9ZUVBtTkNLeXc?oc=5","date":"2025-09-17","type":"deal","source":"The Motley Fool","summary":"2 Growth Stocks to Buy and Hold Forever - The Motley Fool","headline":"2 Growth Stocks to Buy and Hold Forever","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5vaHZYWTBxMXZPZjdlczFiWnJIS05hOExmWEYtT2FBWENrekdiTndVLU1URFVpaU00dVRLVUdqRC05NmJkR1FXMDRaUmpDVGt1QTg4Zm4tTTN0ejAzaE05eklFTWJ5X05SdVAtYXFUN0tNWUlLbF9B?oc=5","date":"2025-09-17","type":"deal","source":"AOL.com","summary":"2 Growth Stocks to Buy and Hold Forever - AOL.com","headline":"2 Growth Stocks to Buy and Hold Forever","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQTURDcW5uVnUtMlRfYjdmMll1eUlTZUY0MTkxQThUTjROUUJvN3RiRVlJbUk2dEdwZW56YTFZMkQ0YzFoWmt6ajlIWjFPY3BRRlU5MWhRWVJVSjBBMjhPLURIdzR6NTIySnhheFFGN2FUSE9tczJKNnVBTXRmR0VTdTQ4S0VlR2dpcGZFRTRZUEhZc1diY3BRMA?oc=5","date":"2025-09-16","type":"deal","source":"The Motley Fool","summary":"1 Reason Intuitive Surgical (ISRG) Is 1 of the Best Healthcare Stocks You Can Buy Today - The Motley Fool","headline":"1 Reason Intuitive Surgical (ISRG) Is 1 of the Best Healthcare Stocks You Can Buy Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOUUp3XzJlT2o2YjdZdGpnNTFvTUNnWko3djhERDBLcWRjcS0zNktkMTRXYnk2aVF6REpkZldGRUdCQ0VzM2cxZFYxZTRHcklrY3ZMeW93SUxlampham9MaTJ6bUhOSDRhaEpWZl9heEVKbThGR2VvZ0lEUHNQQ1dxbE1FQlMwa2pxLTM2aFotSU1McE9LdTBZTl9NZ0UtX012UWZKZUMtV25zWFljb2ZOQ3FTNUFMbkhiUDdlS28zYnV3T1hh?oc=5","date":"2025-09-07","type":"deal","source":"The Globe and Mail","summary":"2 Beaten-Down Stocks to Buy on the Dip - The Globe and Mail","headline":"2 Beaten-Down Stocks to Buy on the Dip","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9CZVE4blhLRXRidDh2a0k4VW5OMUhXVmFMbnZuSWdzWkRENUhIVjFSYmtVVVozdTd3TlhFRUxucTREbURWb1JIWEViR0I3U1pGSkVncFVxUVRJVDRkelpwOE1MQUtObEM3endOaUozSm5oenE5TmxBNVRHZ3YwZw?oc=5","date":"2025-08-17","type":"deal","source":"Yahoo Finance","summary":"If You're in Your 30s, Consider Buying These 2 Healthcare Stocks - Yahoo Finance","headline":"If You're in Your 30s, Consider Buying These 2 Healthcare Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOZ3o3RFlzbmRNbUZpWU4wazllMVM1RndqWXlITmlqT2xIUFJnWDRJeTBCcVRyR1F1UlhRRzFTMWhyR2R2ckdBTXFkUWVuYWpnR1o1Q1I1RlJjd0ZPRlJfUVBQOUF4R2Ixcl9WQ19jTzBpNERRbTYzRTVURzZKUXo3UEhpdl9RVldaLVZYenA3cGkxQUpjeXU3NDNxWFVXWHVCRmhoNGZkYnpEc0ZhQXdEdUpQU0psbTBtUmpyU201Vmw2LWszMmg0bW5OQ1JXb0g2SE1wTnVxdjVNcXVVWVpIRnh3?oc=5","date":"2024-04-18","type":"regulatory","source":"Reuters","summary":"Medical device maker Intuitive beats estimates on strong demand for surgical robots - Reuters","headline":"Medical device maker Intuitive beats estimates on strong demand for surgical robots","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQdllMM1R2eFJob2xNeUNxVnYzME9aUmhOMG9lNFhaZXVWbm9kcXA2SlBFZGRKZFhfVWo2YTEyMFBBUDA2Yy1XSnVLazRURVA5bHkwSThKQnlsZDZSQ2ZoTVVUb3pjMWR3cThZMXoxNkZwX3M1dmpZMzJ4R0ZtQlZWYg?oc=5","date":"2024-03-21","type":"regulatory","source":"MassDevice","summary":"Intuitive Ion wins regulatory approval in China - MassDevice","headline":"Intuitive Ion wins regulatory approval in China","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Medtronic","Stryker","Boston Scientific"],"therapeuticFocus":["Urology","Gynecology","General Surgery"],"financials":{"source":"sec_edgar","revenue":10064700000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":10064700000,"period":"2025-12-31"},{"value":8352100000,"period":"2024-12-31"},{"value":8352100000,"period":"2024-12-31"},{"value":7124100000,"period":"2023-12-31"},{"value":7124100000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":1311800000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":2856000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":20458700000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":468.96,"previousClose":452.95,"fiftyTwoWeekHigh":603.88,"fiftyTwoWeekLow":427.84,"fiftyTwoWeekRange":"427.84 - 603.88","fiftyDayAverage":488.21,"twoHundredDayAverage":506.02,"beta":1.68,"enterpriseValue":155209940992,"forwardPE":41,"priceToBook":9.34,"priceToSales":16.55,"enterpriseToRevenue":15.42,"enterpriseToEbitda":43.62,"pegRatio":2.33,"ebitda":3558000128,"ebitdaMargin":35.4,"freeCashflow":2274837504,"operatingCashflow":3030500096,"totalDebt":170900000,"debtToEquity":1,"currentRatio":4.88,"returnOnAssets":9.4,"returnOnEquity":16.7,"analystRating":"1.9 - Buy","recommendationKey":"buy","numberOfAnalysts":30,"targetMeanPrice":602.74,"targetHighPrice":750,"targetLowPrice":378,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.6,"institutionHeldPercent":89.1,"sharesOutstanding":355169692,"floatShares":352942635,"sharesShort":6347786,"shortRatio":3.94,"shortPercentOfFloat":1.8,"epsTrailing":7.88,"epsForward":11.43,"revenuePerShare":28.2,"bookValue":50.19,"officers":[{"age":59,"name":"Dr. Gary S. Guthart Ph.D.","title":"Executive Chair"},{"age":57,"name":"Mr. David J. Rosa","title":"CEO & Director"},{"age":54,"name":"Mr. Jamie E. Samath","title":"Executive VP, CFO & Enterprise Technology Leader"},{"age":55,"name":"Mr. Gary H. Loeb J.D.","title":"Executive VP and Chief Legal & Compliance Officer"},{"age":55,"name":"Mr. Henry L. Charlton","title":"Executive VP and Chief Commercial & Marketing Officer"},{"age":58,"name":"Mr. Mark P. Brosius","title":"Senior VP and Chief Manufacturing & Supply Chain Officer"},{"age":null,"name":"Mr. Fredrik  Widman","title":"VP, Principal Accounting Officer & Corporate Controller"},{"age":null,"name":"Mr. Milind  Wagle","title":"Chief Information Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://investor.intuitivesurgical.com/phoenix.zhtml?c=122359&p=irol-IRHome","website":"https://www.intuitive.com","phone":"408 523 2100"}}